David R. Cornblath, MD
David R. Cornblath received his MD from Case Western Reserve University and completed his residency and fellowship at the Hospital of the University of Pennsylvania under Prof. A.K. Asbury. He is Professor of Neurology at Johns Hopkins University and Director of the Neurology EMG Laboratory at the Johns Hopkins Hospital. His clinical and research interests are peripheral neuropathies.
Prof. Cornblath has co-authored a book entitled Diagnosis and Management of Peripheral Nerve Disorders and written over 200 articles and chapters. He is Editor-in-Chief of the Journal of the Peripheral Nervous System, Secretary/ Treasurer of the Peripheral Nerve Society, a member of the Board of Directors of the GBS/CIDP Foundation International and the Foundation for Peripheral Neuropathy, and Chair of one of the Hopkins Institutional Review Boards.
-
7:23Overview and Treatment of Guillain-Barr├® Syndrome (GBS)Learn more about the features, symptoms, diagnosis, and treatment of GBS.
Peter Donofrio, MD
Peter D. Donofrio, M.D. is a Professor of Neurology at Vanderbilt University Medical Center. He is a graduate of The Ohio State University School of Medicine and pursued a residency in neurology and a neuromuscular fellowship at the University of Michigan. Dr. Donofrio is board certified in Neurology, Internal Medicine, EMG and Neuromuscular Disorders. He is Chief of the Neuromuscular Section and Director of the EMG lab at Vanderbilt.
Other duties include Directorship of the MDA Clinic and the ALS Clinic. He is a member of the Medical Advisory Committee of the GBS/CIDP International Foundation; Vanderbilt University Medical Center is a certified Center of Excellence for the GBS/CIDP International Foundation. Dr. Donofrio has a special interest in all types of peripheral neuropathies, particularly GBS and CIDP, but also cares for many patients with myasthenia gravis, ALS, and muscle disorders. He is the author of the textbook entitled The Textbook of Peripheral Neuropathy published in April 2012 by Demos Medical.
-
25:18Incidence of GBS and CIDP Following Influenza VaccinationGain an understanding of the existing surveillance data, studies and facts associated with the influenza vaccine as it relates to GBS and CIDP.
Kenneth C. Gorson, M.D.
Kenneth C. Gorson, M.D. is a Professor of Neurology in the Department of Neurology at St. ElizabethÔÇÖs Medical Center, Tufts University School of Medicine, in Boston. Dr. Gorson has published over 90 original peer-reviewed research articles, book chapters, and reviews pertaining to Guillain-Barre┬┤ syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), paraprotein associated neuropathies, vasculitic neuropathy, and various other inflammatory and immune-mediated disorders of the peripheral nervous system. His clinical and research expertise extends to patients with neuropathies associated with diabetes, connective tissue disorders, and cancer, inherited peripheral neuropathies, and disorders of muscle, myasthenia gravis, and amyotrophic lateral sclerosis. Professor Gorson also has extensive expertise in the medical management of numerous chronic neuropathic and musculoskeletal pain disorders. He has been a principal investigator in several clinical research studies, including experimental treatment trials for CIDP, multifocal motor neuropathy, myasthenia gravis, diabetic neuropathy, painful neuropathies, and post-herpetic neuralgia. He has lectured widely to medical specialists and patient support groups on various topics in the field of neuromuscular diseases.
Dr. Gorson is the Chairman of the Global Medical Advisor Board for the GBS/CIDP Foundation international, the United States Principal Investigator and country coordinator for the International Guillain-Barre Outcome Study (IGOS) and also serves on the Steering Committee for IGOS, Secretary for the Inflammatory Neuropathy Consortium, serves on the editorial board for Muscle & Nerve, and is an active member of the American Academy of Neurology (AAN), American Association of Electrodiagnostic Medicine, and Peripheral Nerve Society, and has previously served on the sub-committee responsible for the selection of neuromuscular courses for the annual meeting of the Academy. He also served as a Councilor for the Neuromuscular Section for the AAN.
In his teaching capacity, Dr. Gorson has served as Director of the Tufts Neurology Residency Training Program and was responsible for resident candidate selection, and supervises the daily academic activities of the Neurology resident trainees. He is also an integral part of the teaching staff for the neurology and medical interns and residents at St. ElizabethÔÇÖs Medical Center and medical students from Tufts University School of Medicine.
-
19:15GBS and Zika VirusUnderstand the latest information on the Zika Virus and its relationship to Guillain-Barre┬┤ syndrome
Thomas Harbo, MD, PhD
-
16:21Wear-Off in IVIG and What it Means in Clinical PracticeLearn about wear-off effects in patients with CIDP, the tools available to monitor them, and the methods to combat them and tailor treatment to the patient. -
15:18Guillain-Barre Syndrome (GBS): Typical and Atypical Clinical PresentationsLearn more about the importance of understanding typical and atypical presentations of GBS, including features of clinically distinct variants and subtypes, proper diagnosis, and initiation of appropriate treatment.
Carol L. Koski, MD
-
16:21Wear-Off in IVIG and What it Means in Clinical PracticeLearn about wear-off effects in patients with CIDP, the tools available to monitor them, and the methods to combat them and tailor treatment to the patient.
-
5:51IgG Levels and Wear Off Reflect Administration and OutcomeLearn more about how IgG levels and their wear off reflect treatment administration and outcomes in individual IVIG- or SCIG-treated patients with immunodeficiency and peripheral inflammatory neuropathy disorders.
Richard A. Lewis, MD
Richard A. Lewis, MD is Professor of Neurology at Cedars-Sinai Medical Center in Los Angeles, California where he directs the EMG laboratory and co-directs the neuromuscular clinical program. He is Director of the GBS-CIDP Foundation Center of Excellence at Cedars-Sinai. Prior to his move to California in 2013, he was Associate Chair of Neurology at Wayne State University where he had been for 19 years.
He has been on the Board of Directors of the Peripheral Nerve Society, and on the Steering Committee of the Inflammatory Neuropathy Consortium. He is on the Medical Advisory Boards of the GBS-CIDP Foundation and the Myasthenia Gravis Foundation. He has been involved as an investigator, steering committee member and DSMB member in clinical trials in a number of immune mediated disorders including CIDP, myasthenia gravis and multifocal motor neuropathy.
-
13:53Pathogenesis and Mechanism of Action of Inflammatory NeuropathiesFind out what pathogenic processes are involved in acute and chronic inflammatory neuropathies, including GBS, CIDP, and MMN.